1. Home
  2. XTNT vs TIL Comparison

XTNT vs TIL Comparison

Compare XTNT & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

HOLD

Current Price

$0.58

Market Cap

86.2M

Sector

Health Care

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$8.93

Market Cap

74.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XTNT
TIL
Founded
N/A
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.2M
74.7M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
XTNT
TIL
Price
$0.58
$8.93
Analyst Decision
Strong Buy
Buy
Analyst Count
1
3
Target Price
$1.50
$125.00
AVG Volume (30 Days)
153.6K
67.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
52.54
EPS
0.03
N/A
Revenue
$53,337,000.00
N/A
Revenue This Year
$15.08
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.34
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$5.67
52 Week High
$0.95
$42.75

Technical Indicators

Market Signals
Indicator
XTNT
TIL
Relative Strength Index (RSI) 39.07 61.72
Support Level $0.55 $6.85
Resistance Level $0.68 $11.85
Average True Range (ATR) 0.03 0.53
MACD 0.00 0.31
Stochastic Oscillator 29.09 75.17

Price Performance

Historical Comparison
XTNT
TIL

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: